In TCGA and other GC cohorts, when EBVaGC samples are compared to EBV-negative ones, they demonstrate elevated IFNγ signatures, indicated by higher expression of IFNγ, JAK/STAT signaling components, and several IFNγ-induced genes[4,103]. Here, IFNG is linked to gastric cancer.